Induction of antigen-specific T-cell responses through dendritic cell vaccination in AML: results of a phase I/II trial and ex vivo enhancement by checkpoint blockade.
Oncol. Res. Treat.39, 135-135 (2016)
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.